SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-24-246727
Filing Date
2024-10-29
Accepted
2024-10-29 19:40:55
Documents
2
Group Members
PATRICK SOON-SHIONG

Document Format Files

Seq Description Document Type Size
1 SC 13D d881414dsc13d.htm SC 13D 61995
2 EX-99.1 d881414dex991.htm EX-99.1 4202
  Complete submission text file 0001193125-24-246727.txt   67892
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Subject) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88985 | Film No.: 241407081
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 9922 JEFFERSON BOULEVARD CULVER CITY CA 90232
Business Address 310-836-6400
Nant Capital, LLC (Filed by) CIK: 0001675758 (see all company filings)

IRS No.: 300750613
Type: SC 13D